.png)
.png)
Assistant Professor
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
Nancie Archin received her BS from Stony Brook University in NY and spent a couple of years working at Mount Sinai Medical Center in NYC as a technician doing Alzheimer’s research before pursuing her PhD in Microbiology and Immunology at the University of Texas Health Sciences Center in San Antonio, Texas under the guidance of Dr. Sally Atherton, where her thesis project was to define the mechanisms of Herpes Simplex Virus-1 induced Acute Retinal Necrosis Syndrome using a mouse model system. She then Joined the laboratory of Dr. David Margolis at UT Southwestern Medical Center in Dallas, TX as a post-doctoral fellow where she began her HIV latency studies under the guidance of her mentor, Dr. David Margolis. She moved with the laboratory of Dr. Margolis to the University of North Carolina at Chapel Hill where she continued doing HIV latency work, moving laboratory observations into clinical testing and applications, and eventually joining the faculty at UNC. She is currently an assistant professor at the UNC HIV Cure Center in Chapel Hill. She is the lead author of several key publications, including the first manuscript to demonstrate the ability of latency reversal agents to disrupt latent HIV in humans. She is a recipient of the UNC School of Medicine, Simmons and ACCLAIM Scholarship faculty development awards. She is both, an investigator within Delaney CARE, a consortium of scientists actively pursuing an HIV Cure, and the Women Interagency HIV Study (formerly WIHS, now MWCCS). Her current funded research focuses on understanding sex specific factors that contribute to HIV persistence in women, further defining modalities to disrupt latency and clear latently infected cells, and applying these observations in the clinic
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Friday, October 21, 2022
3:15 PM – 4:30 PM US ET
Friday, October 21, 2022
3:40 PM – 4:05 PM US ET